Z.A. GONCHAROVA, Yu.Yu. POGREBNOVA, N.M. YAROSH

Rostov State Medical University, 29 Nakhichevanskiy pereulok, Rostov-on-Don, Russian Federation, 344022

 Goncharova Z.A. ― D. Med. Sc., Professor of the Department of Nervous Diseases and Neurosurgery, tel. +7-909-421-22-46, e-mail: centrms@mail.ru

Pogrebnova Yu.Yu. ― postgraduate student of the Department of Nervous Diseases and Neurosurgery, tel. +7-988-890-79-88, e-mail: 3ay40n0k@mail.ru

Yaroch N.M. ― neurologist of the Department of Neurology, tel. +7-960-450-49-00, e-mail: yarosh-nats@mail.ru

The article presents literature data and own observation of one of the rarest forms of myelopathy ― post-radiation myelopathy. The possible variants of pathogenesis, stages of development, features of clinical picture and diagnosis of radiation damage to the spinal cord are discussed. A differential-diagnostic algorithm is proposed, which allows to make the final clinical diagnosis by excluding the more common myelitis.

Key words: postradiation myelopathy, myelitis, demyelination, Devic’s disease.

REFERENCES

1. Scott T.F., Frohman E.M., de Seze J., Gronseth G.S., Weinshenker B.G. Evidence-based guideline: clinical evaluation and treatment of transverse myelitis: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology, 2011, 77, pp. 2128-2134.
2. Coderre J.A., Morris G.M., Micca P.L., et al. Late effects of radiation on the central nervous system: role of vascular endothelial damage and glial stem cell survival. Radiat. Res, 2006, 166, pp. 495-503.
3. Wong C.S., Fehlings M.G., Sahgal1 A. Pathobiology of radiation myelopathy and strategies to mitigate injury. Spinal Cord, 2015, 53, pp. 574-580.
4. Mul V.E., de Jong J.M., Murrer L.H., et al. Lhermitte sign and myelopathy after irradiation of the cervical spinal cord in radiotherapy treatment of head and neck cancer. Strahlenther Onkol, 2012, 188, pp. 71-76.
5. Chow B.M., Li Y.Q., Wong C.S. Radiation-induced apoptosis in the adult central nervous system is p53-dependent. Cell Death Differ, 2000, 7, pp. 712-720.
6. Atkinson S., Li Y.Q., Wong C.S. Changes in oligodendrocytes and myelin gene expression after radiation in the rodent spinal cord. Int. J. Radiat. Oncol. Biol. Phys, 2003, 57, pp. 1093-1100.
7. Limoli C.L., Giedzinski E., Baure J., et al. Using superoxide dismutase/catalase mimetics to manipulate the redox environment of neural precursor cells. Radiat. Prot. Dosimetry, 2006, 122, pp. 228-236.
8. Uchida K., Nakajima H., Takamura T., et al. Neurological improvement associated with resolution of irradiation-induced myelopathy: serial magnetic resonance imaging and positron emission tomography findings. J. Neuroimag, 2009, 19, pp. 274-276.
9. Bardychev M.S., Kurpesheva A.K., Pasov V.V. et al. Luchevye povrezhdeniya pri lechenii bolezni Khodzhkina [Radiation injuries in the treatment of Hodgkin’s disease]. Materialy VI Rossiyskoy onkologicheskoy konferentsii. Moscow, 2002.
10. Shnayder N.A., Dykhno Yu.A., Ezhikova V.V., Goncharova Z.A. et al. Paraneoplasticheskiy nevrologicheskiy sindrom [Paraneoplastic neurologic syndrome]. Novosibirsk: Nauka, 2016. 172 p.
11. Philippens M.E., Gambarota G., van der Kogel A.J., Heerschap A. Radiation effects in the rat spinal cord: evaluation with apparent diffusion coefficient versus T2 at serial MR imaging. Radiology, 2009, 250, pp. 387-397.
12. Jacob A., Weinshenker B.G. An approach to the diagnosis of acute transverse myelitis. Semin Liver Dis, 2008, 28 (1), pp. 105-120.
13. Lycklama G., Thompson A., Filippi M., et al. Spinal-cord MRT in multiple sclerosis. Lancet Neurol, 2003, 2 (9), pp. 555-562.
14. Miller D.H., Weinshenker B.G., Filippi M., et al. Differential diagnosis of suspected multiple sclerosis: a consensus approach. Mult. Scler, 2008, 14, pp. 1157-1174.
15. Wingerchuk D.M., Banwell B., Bennett J.L., et al. International consensus diagnostic criteria for neuromyelitisoptica spectrum disorders. Neurology, 2015, 85, pp. 177-189.
16. Jarius S., Wildemann B., Paul F. Neuromyelitisoptica: clinical features, immunopathogenesis and treatment. Clin. Exp. Immunol, 2014, 176, pp. 149-164.
17. Simaniv T.O., Vorob’eva A.A., Smirnova N.V. et al. Opticomielithiakvaporin-associated syndromes. Zhurn. nevrol. i psikhiatr, 2015, 2, pp. 31-37 (in Russ.).